Ensidipine Use Limitations: Patients should be cautious or avoid taking ensidipine under these circumstances

Enasidenib (Enasidenib) is a targeted therapy for acute myeloid leukemia (AML) that carries specific gene mutations. Although its efficacy is significant, in some specific cases, patients need to be particularly careful or even avoid taking it. Next, we will discuss in detail some of the major contraindications to taking ensidipine.

1. Allergy to ensidipine or its ingredients

This drug should never be taken if the patient has an allergic reaction to ensidipine or any of its components. Symptoms of an allergic reaction may include skin rash, hives, and even difficulty breathing. In extreme cases, anaphylactic shock can occur, a life-threatening condition.

2. Severe impairment of liver function

Because ensidipine is primarily metabolized in the liver, use of this drug should be done with extreme caution and may even be avoided in patients with severely impaired liver function. Hepatic insufficiency may affect the metabolism and excretion of drugs, causing drug accumulation in the body, thereby increasing the risk of adverse reactions.

3. Pregnant and lactating women

Pregnant women should avoid taking ensidipine because animal experiments show that the drug may cause adverse effects on the fetus, including malformations. At the same time, since ensidipine may be excreted through breast milk, lactating women should also avoid taking it.

4. Interactions with certain drugs

Ensidipine may interact with other medications that patients are taking, affecting their metabolism and elimination, thereby increasing the risk of adverse reactions. Therefore, before starting ensidipine treatment, patients should inform their doctor in detail about all medications they are taking, including but not limited to prescription drugs, over-the-counter drugs, and nutritional supplements.

5. Risk of arrhythmia

Ensidipine may cause arrhythmias, such asQT interval prolongation and tachycardia. Therefore, in patients with a history of cardiovascular disease or other risk factors for arrhythmias, an electrocardiogram should be obtained before starting treatment and monitored regularly during treatment.

6. Other unspecified risks

Because the long-term safety and effectiveness of ensidipine are not fully understood, patients should exercise caution when choosing to use this drug and follow their physician's advice and guidance for close monitoring and evaluation.

In summary, although ensidipine has shown potential efficacy as a targeted therapeutic drug forAML, in some specific cases, patients and doctors need to jointly conduct a comprehensive evaluation and carefully choose whether to use it. Patients should provide timely feedback to their doctors regarding any possible contraindications or discomforts in order to adjust the treatment plan or explore other treatment avenues.